May 2016 Vol 7, No 4
A new paradigm of survivorship care is needed that attempts to balance the patient’s total well-being against the often toxic treatment of the disease, suggests Deborah Korenstein, MD, Director of Clinical Effectiveness, Memorial Hospital, Memorial Sloan Kettering Cancer Center, New York City.
Linking physicians and patients is a major undertaking, but given the ubiquity of smartphone technology and the rise in app development, the healthcare industry is poised to leverage advances in communication and information exchange.
The American Society of Clinical Oncology (ASCO) maintains that a multidisciplinary team (MDT) is the cornerstone of quality care, yet despite incentives and interest, little is known about how teams affect cancer delivery.
Researchers in Chicago have developed a financial toxicity grading system based on independent and clinically meaningful changes in health-related quality of life.
- 1
- 2
Page 2 of 2
Results 11 - 14 of 14
Results 11 - 14 of 14
